• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

化疗和生物分子治疗在子宫肉瘤治疗中的作用。

Role of chemotherapy and biomolecular therapy in the treatment of uterine sarcomas.

机构信息

Memorial Sloan-Kettering Cancer Center, NY 10065, USA.

出版信息

Best Pract Res Clin Obstet Gynaecol. 2011 Dec;25(6):773-82. doi: 10.1016/j.bpobgyn.2011.06.003. Epub 2011 Jul 14.

DOI:10.1016/j.bpobgyn.2011.06.003
PMID:21752717
Abstract

Uterine sarcomas are rare, high-risk malignancies. Expert histologic review is important for accurate diagnosis. For high-grade leiomyosarcomas, the risk of recurrence is high after complete resection of uterus-limited disease; however, no adjuvant therapy has been proven to improve survival. Chemotherapy regimens with efficacy in treating advanced uterine leiomyosarcoma include gemcitabine-docetaxel, doxorubicin and ifosfamide. Uterine carcinosarcomas also carry a high risk of recurrence. Adjuvant chemotherapy is a standard approach for completely resected and metastatic carcinosarcoma. Active agents include carboplatin, cisplatin, ifosfamide and paclitaxel.

摘要

子宫肉瘤是罕见的、高风险的恶性肿瘤。专家进行组织学审查对于准确诊断很重要。对于高级别平滑肌肉瘤,在子宫局限性疾病完全切除后复发风险较高;然而,尚无辅助治疗被证明可以提高生存率。在治疗晚期子宫平滑肌肉瘤方面有效的化疗方案包括吉西他滨-多西他赛、多柔比星和异环磷酰胺。子宫癌肉瘤也有很高的复发风险。对于完全切除和转移性癌肉瘤,辅助化疗是一种标准方法。有效的药物包括卡铂、顺铂、异环磷酰胺和紫杉醇。

相似文献

1
Role of chemotherapy and biomolecular therapy in the treatment of uterine sarcomas.化疗和生物分子治疗在子宫肉瘤治疗中的作用。
Best Pract Res Clin Obstet Gynaecol. 2011 Dec;25(6):773-82. doi: 10.1016/j.bpobgyn.2011.06.003. Epub 2011 Jul 14.
2
[Chemotherapy and hormone therapy for uterine sarcomas].子宫肉瘤的化疗与激素治疗
Gan To Kagaku Ryoho. 2012 May;39(5):722-5.
3
Safety and efficacy of adjuvant single-agent ifosfamide in uterine sarcoma.辅助单药异环磷酰胺治疗子宫肉瘤的安全性和有效性。
Gynecol Oncol. 2000 Aug;78(2):221-7. doi: 10.1006/gyno.2000.5875.
4
The management of patients with uterine sarcoma: a debated clinical challenge.子宫肉瘤患者的管理:一项存在争议的临床挑战。
Crit Rev Oncol Hematol. 2008 Feb;65(2):129-42. doi: 10.1016/j.critrevonc.2007.06.011. Epub 2007 Aug 13.
5
Adjuvant ifosfamide and cisplatin in patients with completely resected stage I or II carcinosarcomas (mixed mesodermal tumors) of the uterus: a Gynecologic Oncology Group study.辅助性异环磷酰胺和顺铂用于完全切除的Ⅰ期或Ⅱ期子宫癌肉瘤(混合性中胚叶肿瘤)患者:一项妇科肿瘤学组的研究
Gynecol Oncol. 2005 Mar;96(3):630-4. doi: 10.1016/j.ygyno.2004.11.022.
6
Preoperative diagnosis and treatment results in 106 patients with uterine sarcoma in Hokkaido, Japan.日本北海道106例子宫肉瘤患者的术前诊断与治疗结果。
Oncology. 2004;67(1):33-9. doi: 10.1159/000080283.
7
Adjuvant chemotherapy in early stage uterine sarcomas: an open question.早期子宫肉瘤的辅助化疗:一个悬而未决的问题。
Eur J Gynaecol Oncol. 2001;22(5):352-7.
8
Chemotherapy for Uterine Carcinosarcoma with Carboplatin, Ifosfamide and Mesna.卡铂、异环磷酰胺和美司钠治疗子宫癌肉瘤的化疗
Anticancer Res. 2015 Sep;35(9):4841-7.
9
Optimal management of uterine leiomyosarcoma.子宫平滑肌肉瘤的最佳治疗方法。
Expert Rev Anticancer Ther. 2010 Feb;10(2):153-69. doi: 10.1586/era.09.187.
10
Cisplatin-based chemotherapy regimen (DECAV) for uterine sarcomas.用于子宫肉瘤的基于顺铂的化疗方案(DECAV)。
Int J Gynecol Cancer. 2002 Nov-Dec;12(6):749-54. doi: 10.1046/j.1525-1438.2002.01144.x.

引用本文的文献

1
Upregulated MELK Leads to Doxorubicin Chemoresistance and M2 Macrophage Polarization via the miR-34a/JAK2/STAT3 Pathway in Uterine Leiomyosarcoma.上调的MELK通过miR-34a/JAK2/STAT3通路导致子宫平滑肌肉瘤对阿霉素产生化学抗性并诱导M2巨噬细胞极化。
Front Oncol. 2020 Apr 22;10:453. doi: 10.3389/fonc.2020.00453. eCollection 2020.
2
Significance of Lymphovascular Space Invasion by the Sarcomatous Component in Uterine Carcinosarcoma.肉瘤成分的淋巴管血管侵犯对子宫癌肉瘤的意义。
Ann Surg Oncol. 2018 Sep;25(9):2756-2766. doi: 10.1245/s10434-018-6547-x. Epub 2018 Jul 3.
3
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in seven patients with peritoneal sarcomatosis from uterine sarcoma.
7例子宫肉瘤腹膜转移患者的肿瘤细胞减灭术及腹腔热灌注化疗
Clin Case Rep. 2018 May 2;6(6):1142-1152. doi: 10.1002/ccr3.1491. eCollection 2018 Jun.
4
Endometrial stromal sarcoma in combination with mixed type endometrial carcinomas: A case report and literature review.子宫内膜间质肉瘤合并混合型子宫内膜癌:一例报告及文献复习
Medicine (Baltimore). 2017 Dec;96(49):e8928. doi: 10.1097/MD.0000000000008928.
5
Pioglitazone induces cell growth arrest and activates mitochondrial apoptosis in human uterine leiomyosarcoma cells by a peroxisome proliferator-activated receptor γ-independent mechanism.吡格列酮通过一种不依赖过氧化物酶体增殖物激活受体γ的机制诱导人子宫平滑肌肉瘤细胞的细胞生长停滞并激活线粒体凋亡。
Naunyn Schmiedebergs Arch Pharmacol. 2017 Jan;390(1):37-48. doi: 10.1007/s00210-016-1291-x. Epub 2016 Sep 23.
6
PI3K/AKT/mTOR inhibition in combination with doxorubicin is an effective therapy for leiomyosarcoma.磷脂酰肌醇-3激酶/蛋白激酶B/哺乳动物雷帕霉素靶蛋白(PI3K/AKT/mTOR)抑制与阿霉素联合使用是治疗平滑肌肉瘤的有效疗法。
J Transl Med. 2016 Mar 8;14:67. doi: 10.1186/s12967-016-0814-z.
7
Exome Sequencing of Uterine Leiomyosarcomas Identifies Frequent Mutations in TP53, ATRX, and MED12.子宫平滑肌肉瘤的外显子测序鉴定出TP53、ATRX和MED12的常见突变。
PLoS Genet. 2016 Feb 18;12(2):e1005850. doi: 10.1371/journal.pgen.1005850. eCollection 2016 Feb.
8
Improved clinical trial enrollments for uterine leiomyosarcoma patients after gynecologic oncology partnership with a sarcoma center.妇科肿瘤学与肉瘤中心合作后,子宫平滑肌肉瘤患者的临床试验入组情况得到改善。
Gynecol Oncol. 2016 Feb;140(2):307-12. doi: 10.1016/j.ygyno.2015.12.016. Epub 2015 Dec 21.
9
Long lasting clinical response to chemotherapy for advanced uterine leiomyosarcoma: a case report.晚期子宫平滑肌肉瘤化疗的长期临床反应:一例报告
J Med Case Rep. 2013 Jan 24;7:29. doi: 10.1186/1752-1947-7-29.